U.S., June 10 -- ClinicalTrials.gov registry received information related to the study (NCT07635082) titled 'Extended Letrozole Protocol Versus Letrozole Plus Inositol for Induction of Ovulation in Letrozole Resistant PCOS Women' on May 18.
Brief Summary: Extended letrozole protocol versus letrozole plus Inositol for Induction of ovulation in letrozole resistant PCOS Women
Study Start Date: Feb. 01, 2024
Study Type: INTERVENTIONAL
Condition:
Polycystic Ovary Syndrome (PCOS) Women
Polycystic Ovary Syndrome
Intervention:
DRUG: ELP (Extended Letrozole Protocol)
? ELP (Extended Letrozole Protocol)
Participants allocated to this arm will receive letrozole 5 mg orally once daily, starting on day 2 of the menstrual cycle and continued for...